You are here:

Trial design

Little cartoon people around a table

The design of a clinical trial is very important as it ensures that the trial is given approval to proceed from the ethics committee and, in the case of a drug trial, the regulatory agencies.

Doctors, nurses, patients and researchers work together with statisticians, trial managers and in the case of drug trials, representatives from pharmaceutical companies, to design the best possible trial.

The design of a clinical trial is very important as it ensures that the trial is given approval to proceed from the ethics committee and, in the case of a drug trial, the regulatory agencies. Doctors, nurses, patients and researchers work together with statisticians, trial managers and in the case of drug trials, representatives from pharmaceutical companies, to design the best possible trial.

The trial design forms the basis of the trial protocol which is a blue print for how a trial will be carried out.

The protocol will contain the following information:

  • The question the trial is asking
  • The number of people that will be involved and for how long
  • Which treatments will be compared and how
  • Which tests participants will undergo and when they must have them
  • Details about how and when data will be collected
  • Who can and can not take part – the inclusion and exclusion criteria.

All clinical trials have strict guidelines as to who may participate. These are known as inclusion and exclusion criteria. The inclusion criteria may include things like age, type of MS and degree of disability. The exclusion criteria might rule out people who have taken certain drugs, pregnant or nursing mothers etc. The purpose of the inclusion and exclusion criteria is to ensure that the appropriate trial participants are identified, to enhance safety and to ensure that the researchers are able to provide answers to the questions being studied. The doctor who is responsible for the trial is ultimately responsible for which patients are included or excluded.

The trials carried out in the development of a drug can be split into four phases and each phase requires a different approach to trial design. It should also be noted that the phases may overlap.

Print this page